Clinical trials
Phase 1/2 Hematologic Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Gamida Cell ltd | 1 |
| Glycostem Therapeutics BV | 1 |
| Incyte Corporation | 1 |
| Novartis Pharmaceuticals | 1 |
| Radboud University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 6 |
| Leukemia, Myeloid, Acute | 3 |
| Myelodysplastic Syndromes | 2 |
| Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Leukemia | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Primary Myelofibrosis | 1 |
| Small Cell Lung Carcinoma | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.